Chemical Firm with specialization in Fantastic chemical substances, Speciality chemical substances, and Efficiency Chemical compounds which cater to a number of industries like water therapy, fertilizers, and prescription drugs is in focus after reporting its Q3 Outcomes.
Inventory Worth Motion
With a market capitalization of Rs. 970 Crore, the inventory of Indo Amines opened at Rs. 138.05 up 1.20 p.c from yesterday’s shut, however later fell to a low of 130 and made a pointy restoration of over 7% from the underside. Moreover, the 1 month’s return for the inventory is -7 p.c, and the previous 5-year return is 21 p.c.
Q3FY25 Outcomes
The corporate reported a 33.45 p.c YoY enhance in income from operations from Rs.193.95 Crore in Q3FY24 to Rs. 258.84 Crore in Q3FY25. On a QoQ foundation, the corporate reported a lower of three.90 p.c in income from operations from Rs. 269.35 Crore within the earlier quarter.
Their Web revenue noticed a 15.17 p.c YoY enhance from Rs. 9.82 Crore to Rs. 11.31 Crore for a similar interval. On a QoQ, foundation their internet income additionally noticed a lower of 17.80 p.c from Rs. 13.76 Crore for a similar interval.
The Debt to Fairness ratio is 0.85 for Q3FY25 in comparison with 0.90 for Q3FY24, the Debt to Asset ratio is 0.36 in comparison with 0.37 for a similar interval, and the PE ratio stands at 18.61 in comparison with the business PE of 53.28.
Concerning the Firm
Indo Amines Restricted is an Indian chemical manufacturing firm specializing in tremendous, specialty, and efficiency chemical substances. Established in 1994, the corporate operates a number of manufacturing amenities throughout India, supplying merchandise to industries resembling prescription drugs, agrochemicals, petrochemicals, highway development, and perfumery. Their in depth product portfolio contains aliphatic and fragrant amines, fatty acids, amides, emulsifiers, and corrosion inhibitors, amongst others.
Written By Abhishek Das
Disclaimer
The views and funding ideas expressed by funding consultants/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator will not be answerable for any losses triggered because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
